Neoadjuvant chemotherapy and perioperative cardiotoxicity
Yingzhou Tu, Suli Zhou, Haoran Wang, Peiyao Zhang, Cunming Liu, Changmao Zhu, Chun Yang · 2024
Read Neoadjuvant chemotherapy and perioperative cardiotoxicity by Yingzhou Tu, Suli Zhou, Haoran Wang, Peiyao Zhang, Cunming Liu, Changmao Zhu, Chun Yang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13001760.txt.
Description
Yingzhou Tu and six colleagues review heart damage linked to chemotherapy given before cancer surgery. Neoadjuvant chemotherapy shrinks tumors, lowers their stage, and clears possible small metastases before an operation. Those benefits make surgery more likely to succeed. The same drugs, however, can injure the heart. Reported problems include restricted blood flow to heart muscle, abnormal rhythms, high blood pressure, and heart failure.
The twenty twenty-four review lays out typical treatment protocols for this pre-surgery chemotherapy. It then turns to anesthesia practice during the operation that follows. Precise anesthesia management and heart-protective strategies can reduce risk for these patients. The authors argue such care supports both safer surgery and better long-term survival.
Catalog record
| CREATOR | Yingzhou Tu, Suli Zhou, Haoran Wang, Peiyao Zhang, Cunming Liu, Changmao Zhu, Chun Yang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |